CBI team arrests Joint Drug Controller for accepting bribe from a private company director

New Delhi: The Central Bureau of Investigation has apprehended a Joint Drug Controller (JDC), posted at CDSCO (Central Drugs Standard Control Organisation()Headquarters, New Delhi and a director of private company based at Delhi in an alleged bribery of Rs. four lakh.

A case was registered against a Joint Drug Controller (India) (JDC), CDSCO Headquarters, New Delhi and others including Directors, Associate Vice President & Head-National Regulatory Affairs (NRA) of separate private companies, two based at New Delhi and another at Bengaluru; Assistant Drug Inspector (ADI), CDSCO, New Delhi and other unknown officials of CDSCO. It was alleged in FIR that the accused was trying to exert undue influence on officers of CDSCO under Directorate General of Health Services. It is alleged that influence was for waiving the Phase III trial of “Insulin Aspart Injection” and the accused agreed to pay bribe amount of Rs.9,00,000/- to JDC for favorably processing the said three files related to private company based at Bangalore and also for favourably recommending the file of “Insulin Aspart injection” to the Subject Expert Committee (SEC) meeting.

In fact, CBI had laid a trap wherein the JDC of CDSCO was caught while accepting bribe of Rs. 4,00,000/- from the Director of Delhi based private company and meanwhile, the said Director of Delhi based private company was also caught with Drug Controller.

Related Posts

  • Pharma
  • December 23, 2024
  • 66 views
Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

India’s healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According…

  • Pharma
  • December 23, 2024
  • 95 views
NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 65 new drug formulations and notified ceiling price fixation of 13 formulations. The regulatory body, under the Department of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

India-Latin America trade and collaboration prospects discussed at Kerala University conference

India-Latin America trade and collaboration prospects discussed at Kerala University conference

Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt